Stigma Grow

Data Snapshot: May 05, 2026
Stigma Grow Cannabis Brand Logo
$100K+

Apr-2026

Sales

Neutral

Trend

6-Month

13

Product Count

SKUs

Stigma Grow

Overview

Stigma Grow is a pioneering Alberta-based company, specializing in the cultivation of top-tier cannabis and the extraction of high-terpene cannabis extracts. As a wholly owned subsidiary of the Canadian cannabis company, CanadaBis Capital, it strives to offer consumers highly potent and quality-driven cannabis products. Recognised in the "Green Rush" of the cannabis industry, Stigma Grow stands out for its innovative approach to cannabis cultivation and extraction techniques, highlighting a global future perspective on cannabis as a potentially mainstream pain medicine.
Markets

Stigma Grow Locations

Product Trends

Stigma Grow Categories

Stigma Grow Sales

Market Insights Snapshot

Stigma Grow Historical Sales by Category

Stigma Grow has shown a consistent performance across the Capsules category in Alberta, maintaining a steady rank of 4th place from January through April 2026. Despite this stability in ranking, there is a noticeable fluctuation in sales figures, with a peak in March followed by a decline in April. In British Columbia, the Capsules category exhibited more volatility, with rankings ranging from 5th to 9th place over the same period, indicating a more competitive market environment. Meanwhile, in Ontario, Stigma Grow maintained a consistent 10th place ranking, suggesting a stable yet modest presence in the market.

In the Concentrates category, Stigma Grow's performance in Alberta showed some variability, with rankings fluctuating between 8th and 10th place from January to April. Notably, the brand climbed back to 8th place in April, indicating a potential recovery or strategic adjustment. Conversely, in British Columbia, the brand consistently hovered around the 18th to 20th positions, suggesting challenges in gaining a stronger foothold in this category. The absence of Stigma Grow in the top 30 rankings in other states or categories could imply either a strategic focus on specific markets or a need for enhanced competitiveness in those areas. This selective presence highlights the importance of understanding regional market dynamics and consumer preferences.

Apr-2026 Rank
Capsules
Concentrates
4
8
9
19
10
Stigma Grow

Competitive Landscape

In the Alberta concentrates market, Stigma Grow has demonstrated resilience amidst fluctuating rankings and sales figures. Over the first four months of 2026, Stigma Grow's rank shifted from 8th to 10th and back to 8th, indicating a competitive but stable presence. This fluctuation is notably influenced by brands like Nugz (Canada), which consistently outperformed Stigma Grow, maintaining a top 6 position throughout the period. Meanwhile, The Goo! showed a dramatic rise from 14th in February to 5th by April, suggesting a potential threat to Stigma Grow's market share. Additionally, SUGR experienced a decline from 4th to 9th, which could have provided an opportunity for Stigma Grow to capture more market share, yet Stigma Grow's sales only slightly increased in April. The absence of HotBox (Canada) in the top 20 in January, followed by its re-entry, highlights the dynamic nature of this market. Overall, Stigma Grow's ability to maintain its rank amidst these shifts suggests a solid brand presence, but it must strategize to capitalize on competitors' fluctuations to enhance its market position.

Stigma Grow market ranking for AB Concentrates

Stigma Grow

Notable Products

In April 2026, Phoenix Tears RSO (1g) from Stigma Grow maintained its top position in the Concentrates category with a notable sales figure of 4278 units, reflecting consistent performance as it has held the number one rank since January. Indica RSO Capsules 25-Pack (250mg) remained steady at the second rank, despite a decrease in sales compared to previous months. CBD Softgels 15-Pack (750mg CBD) improved its standing from fifth to third place, indicating a resurgence in demand. Phoenix Tears Honey Oil (1g) consistently held the fourth rank, while Phoenix Tears Resin (1g) reappeared in the rankings at fifth place after not being ranked in February and March. Overall, the rankings for Stigma Grow products show a stable demand for their top-performing items, with slight variations in sales figures across the months.

Product Rank
Category
Jan-2026
Feb-2026
Mar-2026
Apr-2026
Phoenix Tears RSO (1g)
Concentrates
1
1
1
1
Indica RSO Capsules 25-Pack (250mg)
Capsules
2
2
2
2
CBD Softgels 15-Pack (750mg CBD)
Capsules
3
5
3
3
Phoenix Tears Honey Oil (1g)
Concentrates
4
3
4
4
Phoenix Tears Resin (1g)
Concentrates
5
>5
>5
5
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market